YÜKSEL, M. Et Al. 2019. Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT. 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) .

YÜKSEL, M., CENGİZ SEVAL, G., KİRCİLİ, E., D,, K., ÖZTÜRK, C., NARLI ÖZDEMİR, Z., ... ÇINAR, G.(2019). Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT . 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)

YÜKSEL, Et Al. "Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT," 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), 2019

YÜKSEL, OSMAN Et Al. "Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT." 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , 2019

YÜKSEL, M. Et Al. (2019) . "Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT." 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) .

@conferencepaper{conferencepaper, author={ OSMAN İLHAN Et Al. }, title={Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT}, congress name={45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)}, city={}, country={}, year={2019}}